The study also reported changes in glucose tolerance, insulin sensitivity and circulating insulin
Cnh bo: Nu bn ang mang thai, cho con b, ang dng bt k loi no khc hoc c bt k tnh trng sc khe no, hy tham kho kin bc s trc khi s dng
If you've started a GLP-1 medication like Wegovy or Zepbound and you're wondering whether bariatric surgery is still on the table the short answer is yes
The duration of treatment depends on the patients medical condition, kidney function, and response to therapy, so regular medical follow-up is recommended.
Larger randomized placebo-controlled trials including a variety of patient populations (ie, those with metabolic syndrome versus those without) are needed to confirm efficacy of GLP-1RAs according to patient type
This dual mechanismdirect metabolic effects plus weight-related improvementscreates measurable improvements in lipid panels within 812 weeks